372320.KQ Curocell Inc. (큐로셀) Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
01:09
Apr 30
Apr 30
Curocell approval may lift IPO cohort.
Curocell received a new drug approval from the Korean regulator, which could improve returns for the 2021-2023 IPO cohort that has been weak. The approval is a positive catalyst for the stock.
MED
00:25
Apr 21
Apr 21
Korean CAR-T names gain deal momentum
Eli Lilly's CAR-T deal and upcoming medical conference momentum highlight Korean CAR-T names with recognized technology.
MED
About 372320.KQ Investor Commentary
Across the available history and selected sources, Buzzberg tracks 372320.KQ (Curocell Inc. (큐로셀)) across 2 sources: 2 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Latest voices: Kim Seon-ah, Lee Ju-hyeon.